Chiesi USA recalls
Chiesi USA has 5 recalls on record with the FDA and USDA, the earliest in 2019 and the latest reported on 9 Sep 2026. 3 are still ongoing. 3 were reported in the last 12 months. The most frequent reason is potency & assay.
Total recalls5since 2019
Last 12 months3reported
Class I00% of total
Ongoing3latest 9 Sep 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 4 80%Class III 1 20%
Why chiesi usa is recalled
Product types
Brands
By year
Ongoing chiesi usa recalls
3 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Revcovi (elapegademase-lvlr) Injection, 2.4mg/ (1.6 mg/mL) recalledRevcovi | Chiesi USA | Potency & Assay | MO, TN |
| Drug | CLASS II | Cleviprex (clevidipine injectable emulsion) 50 mg recalled by Chiesi USACleviprex | Chiesi USA | Sterility | Nationwide |
| Drug | CLASS II | Curosurf (poractant alfa), 240 mg recalled by Chiesi USACurosurf | Chiesi USA | Sterility | Nationwide |
All chiesi usa recalls, newest first
5 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Revcovi (elapegademase-lvlr) Injection, 2.4mg/ (1.6 mg/mL) recalledRevcovi | Chiesi USA | Potency & Assay | MO, TN |
| Drug | CLASS II | Cleviprex (clevidipine injectable emulsion) 50 mg recalled by Chiesi USACleviprex | Chiesi USA | Sterility | Nationwide |
| Drug | CLASS II | Curosurf (poractant alfa), 240 mg recalled by Chiesi USACurosurf | Chiesi USA | Sterility | Nationwide |
| Drug | CLASS II | Zyflo CR (zileuton) extended-release tablets, 600 mg recalled | Chiesi USA | Potency & Assay | Nationwide |
| Drug | CLASS II | Zileuton Extended-Release Tablets, 600 mg recalled by Chiesi USA | Chiesi USA | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.